Invention Publication
- Patent Title: METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE
-
Application No.: US18527060Application Date: 2023-12-01
-
Publication No.: US20240350462A1Publication Date: 2024-10-24
- Inventor: Takashi Kei Kishimoto
- Applicant: Selecta Biosciences, Inc.
- Applicant Address: US MA Watertown
- Assignee: Selecta Biosciences, Inc.
- Current Assignee: Selecta Biosciences, Inc.
- Current Assignee Address: US MA Watertown
- Main IPC: A61K31/436
- IPC: A61K31/436 ; A61K9/00 ; A61K9/127 ; A61K9/51 ; A61K31/192 ; A61K38/19 ; A61K38/21 ; A61K38/37 ; A61K38/43 ; A61K38/47 ; A61K39/00 ; A61K39/395 ; A61K45/06 ; A61K47/69 ; C07K16/18 ; C07K16/24 ; C07K16/40
Abstract:
This invention relates to methods that provide immunosuppressants and therapeutic macromolecules that are administered within a pharmacodynamically effective window of the immunosuppressants to induce immune tolerance to the therapeutic macromolecules. The methods allow shifting the immune response in favor of tolerogenic immune response development specific to the therapeutic macromolecule.
Information query
IPC分类:
